ArticleJournal of cancer research and clinical oncology2024

Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan.

Yosuke Hirasawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.